Conflicts of Interest The authors declare no conflicts of interest. References 1, , and , “The Translational Revolution and Use of Biologics in Patients With Inflammatory Skin Diseases,” Journal of Allergy and Clinical Immunology 135, no. 2 (2015): 324–336. 2, , , et al., “Patient Burden of Moderate to Severe Atopic Dermatitis (AD): Insights From a Phase 2b Clinical Trial of Dupilumab in Adults,” Journal of the American Academy of Dermatology 74, no. 3 (2016): 491–498.